107 related articles for article (PubMed ID: 16514819)
1. [Use of metformin (siofor) in patients with gout and insulin resistance (pilot 6-month results)].
Barskova VG; Eliseev MS; Nasonov EL; Volkov AV; Tsapina TN; Zilov AV; Iakunina IA; Il'inykh EV; Kudaeva FM
Ter Arkh; 2005; 77(12):44-9. PubMed ID: 16514819
[TBL] [Abstract][Full Text] [Related]
2. [Effect of metformin on the clinical course of gout and insulin resistance].
Barskova VG; Eliseev MS; Kudaeva FM; Aleksandrova EN; Volkov AV; Nasonova VA; Nasonov EL
Klin Med (Mosk); 2009; 87(7):41-6. PubMed ID: 19705791
[TBL] [Abstract][Full Text] [Related]
3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
4. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
[TBL] [Abstract][Full Text] [Related]
6. [Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease].
Barskova VG; Eliseev MS; Nasonov EL; Iakunina IA; Zilov AV; Il'inykh EV
Ter Arkh; 2004; 76(5):51-6. PubMed ID: 15230133
[TBL] [Abstract][Full Text] [Related]
7. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
Gao H; Xiao W; Wang C; Zhang J; Yang Y; Yang J; Yang W; Hong T
Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
9. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
11. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R
Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
[TBL] [Abstract][Full Text] [Related]
12. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
[TBL] [Abstract][Full Text] [Related]
13. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
Moon RJ; Bascombe LA; Holt RI
Diabetes Obes Metab; 2007 Jan; 9(1):143-5. PubMed ID: 17199734
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
Durham AE; Rendle DI; Newton JE
Equine Vet J; 2008 Jul; 40(5):493-500. PubMed ID: 18482898
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects.
Tamura Y; Watada H; Sato F; Kumashiro N; Sakurai Y; Hirose T; Tanaka Y; Kawamori R
Diabetes Obes Metab; 2008 Sep; 10(9):733-8. PubMed ID: 17941868
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.
Bellot-Rojas P; Posadas-Sanchez R; Caracas-Portilla N; Zamora-Gonzalez J; Cardoso-Saldaña G; Jurado-Santacruz F; Posadas-Romero C
J Drugs Dermatol; 2006 Oct; 5(9):884-9. PubMed ID: 17039655
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
